Natural Capsules Share Price

Natural Capsules

CMP as on27-May-22 15:29

₹ 430.00
-10.25 -2.33%

Open

₹ 445.00

Turnover (lac)

₹ 32

Prev. Close

₹ 440.25

Day's Vol (shares)

₹ 7,620

Day's Range

₹ 427.05
₹ 458.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 02-May-2022 - -
Dividend & Audited Results & Rights Issue NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2022 ,inter alia, to consider and approve 1. the Audited Consolidated & Standalone Financial Results of the Company for the Quarter & Financial Year ended March 31st 2022. 2. To recommend dividend if any, on the equity shares of the Company; 3. To discuss on making further call on balance right issue money; Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Companys Code of Conduct for Prevention of Insider Trading and Code of Corporate Disclosure Practices, we wish to inform that the Trading Window for dealing in the equity shares of the Company has remained closed for all Designated Person and their immediate relatives w.e.f. 01st April 2022 till the conclusion of 48 hours after the declaration of financial results of the Company for the Quarter and Financial year ended 31st March, 2022. We request you to kindly take the aforesaid information on record for dissemination through your website. This is to inform that the Board of the Directors at their meeting held today, i.e. Monday, May 9, 2022, have recommended dividend of Re.1/- per equity share of Rs. 10/- each subject to the approval of the members. A. This is to inform that the Board of the Directors at their meeting held today, i.e. Monday, May 9, 2022, have: 1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2022. 2. Recommended dividend of Re.1/- per equity share of Rs. 10/- each subject to the approval of the members. 3. Approval on making first call money of 25%. The record date for the same is 25.05.2022. 4. Considered and approved Appointment of Mr. R K Prasad as new Chief Financial officer & Key Managerial Personnel of the Company with immediate effect. 5. Considered retirement of Mr. Prasanna Junnarkar from the services of the Company as Chief Financial Officer on attaining superannuation. This is to inform that the Board of the Directors at their meeting held today, i.e. Monday, May 9, 2022, have approved on making first call money of 25%. The record date for the same is 25.05.2022. (As Per BSE Announcement Dated on 09.05.2022) This is to inform that the Board of the Directors at their meeting held on Monday, May 9, 2022, Considered and approved Appointment of Mr. R K Prasad as new Chief Financial officer & Key Managerial Personnel of the Company with immediate effect. (As Per BSE Announcement Dated on 10.05.2022)
Board Meeting - 25-Jan-2022 - -
NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2022 inter alia to consider and approve 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended December 31 2021; 2. To consider any other matter as the Board may think fit. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading and Code of Corporate Disclosure Practices we wish to inform that the Trading Window for dealing in the equity shares of the Company has remained closed for all Designated Person and their immediate relatives w.e.f. January 01 2022 till the conclusion of 48 hours after the declaration of Unaudited financial results of the Company for the Quarter ended December 31 2021. We request you to kindly take the aforesaid information on record for dissemination through your website. The Board Meeting to be held on 01/02/2022 has been revised to 08/02/2022 The Board Meeting to be held on 01/02/2022 has been revised to 08/02/2022 (As Per BSE Announcement Dated 29/01/2022) This is to inform that the Board of the Directors at their meeting held today, i.e. Tuesday, February 08, 2022, inter alia has transacted the following: 1. Adoption of Unaudited Standalone and Consolidated Financial Results for the quarter ended December 31, 2021. Further in compliance with regulation 33 of SEBI (Listing Obligations and Disclosures Requirements), Regulations 2015, we submit herewith, the Unaudited Standalone and Consolidated financial results along with Limited Review Report for the quarter ended December 31, 2021. The Board Meeting commenced at 04.00 PM and concluded at 06.00 PM. Kindly take the aforesaid information on record in compliance of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. This is to inform that the Board of the Directors at their meeting held today, i.e. Tuesday, February 08, 2022, inter alia has transacted the following: 1. Adoption of Unaudited Standalone and Consolidated Financial Results for the quarter ended December 31, 2021. Further in compliance with regulation 33 of SEBI (Listing Obligations and Disclosures Requirements), Regulations 2015, we submit herewith, the Unaudited Standalone and Consolidated financial results along with Limited Review Report for the quarter ended December 31, 2021. The Board Meeting commenced at 04.00 PM and concluded at 06.00 PM. Kindly take the aforesaid information on record in compliance of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. (As per BSE Announcement Dated on 08/02/2022)
Board Meeting - 23-Dec-2021 - -
NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/12/2021 inter alia to consider and approve we wish to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday 28th day of December 2021 interalia to consider discuss and decide the following businesses- 1. To consider and approve allotment of Equity shares on Rights basis to eligible Equity Shareholders as on the record Date. 2. Any other businesses as may be considered necessary. This is further to our earlier letter dated December 23, 2021 intimating the date of the meeting of Board of Director (Board) of Natural Capsules Limited for approving the allotment of Equity shares to eligible Equity Shareholders (Issue). In relation to the aforesaid issue and pursuant to the finalization of Basis of Allotment for the Issue, approved by BSE Limited, the Board of Directors considered and approved the allotment of Partly Paid 31,16,350 Equity Shares of Rs. 100 each aggregating to Rs.3,116.35 lacs (Rs. 25 each was called on application) on Rights basis to eligible Equity Shareholders as on the Record Date i.e. November 12, 2021. The meeting commenced at 06.00 PM and concluded at 07.10 PM. You are requested to take the information on record and oblige (As Per BSE Announcement dated on 28.12.2021)
Board Meeting - 25-Oct-2021 - -
Rights Issue & Quarterly Results Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform that the Board of Directors of the Company at their meeting held today i.e. on October 30, 2021 at its registered office, inter alia, considered and approved the business as per the attachment. (As per BSE Announcement Dated on 30/10/2021)
Board Meeting - 31-Jul-2021 - -
NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2021 ,inter alia, to consider and approve 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30, 2021. 2. To issue the share on rights basis. Natural Capsules Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled on August 07, 2021, inter alia, to consider and take on record the following items: 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30, 2021. 2. To Consider issue of Equity Shares on rights basis. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Companys Code of Conduct Prevention of Insider Trading and Code of Corporate Disclosure Practices, the Trading Window for dealing in the equity shares of the Company has remained closed for all Designated Person and their immediate relatives w.e.f July 01, 2021 till the conclusion of 48 hours atter he declaration of Unaudited financial results of the Company for the Quarter ended June 30, 2021. (As Per BSE Announcement dated on 02.08.2021) Natural Capsules Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 06 2021 inter alia has approved the issue of equity shares of Rs. 10/- each on a Rights basis in the ratio of one share for every two shares held on the record date at a premium of Rs. 90/- per share. The details of the issue including the calls will be decided by the sub committee of the Board in consultation with Companys Investment Banker for the Rights issue. (As Per BSE Announcement Dated on 8/7/2021 8:36:26 AM)
Board Meeting - 15-Jul-2021 - -
Outcome of Board Meeting.
Board Meeting - 24-May-2021 - -
NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/05/2021 ,inter alia, to consider and approve Notice of 139th Board Meeting is scheduled on Monday, the 31st day of May 2021. Outcome of 139th Board Meeting held on May 31, 2021 Results - Financial Results for March 31, 2021 (Consolidated & Standalone) Recommended dividend of Rs.1 per equity share of Rs. 10/- each subject to the approval of the members. (As Per BSE Announcement Dated 31.05.2021) Natural Capsules Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 31, 2021, inter alia, have: 1. Recommended dividend of Re. 1 per equity share of Rs. 10/- each subject to the approval of the members. 2. Convening the 28th Annual General Meeting of the Company on July 15, 2021. (As Per BSE Announcement Dated 01.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity